Investigation of Insulin-Like Growth Factor 2 mRNA Binding Protein 2 Gene Polymorphisms in Type 2 Diabetes Patients
Öz
Background/Aims: Type 2 diabetes (T2D) whose prevalance differs in different populations is a multifactorial disease. T2D is describes a group of clinical syndromes resulting from glucose metabolism disorders triggered by genetic or environmental factors. Insulin-like growth factor 2 mRNA binding protein 2 (IGF2BP2) gene participates in insulin signaling pathway and is involved in insulin secretion. SNPs in one of these genes, IGF2BP2 gene (rs1470579 and rs4402960), have been reported to partially increase the risk of type II diabetes. The aim of this study was to investigate in a Turkish population identified associations of IGF2BP2 variants rs4402960 and rs1470579 with T2D.
Methods: We genotyped two SNPs of IGF2BP2 gene, rs1470579 and rs4402960 in 100 healthy individuals and 100 patients. DNA isolation was performed on peripheral blood samples from patients and healthy groups. The molecular analysis of rs1470579 and rs4402960 polymorphisms of IGF2BP2 gene of each individual was performed by using Real-Time PCR (Applied Biosystems) method. Relationships of genotypes and alleles frequency of IGF2BP2 polymorphisms and T2D were examined by "Chi-square" or "Likelihood ratio" tests.
Results: As a result of the genotype and allele distributions; there was association between type II diabetes patients and control group for IGF2BP2 rs1470579 (A/C) gene polymorphism (p=0.0123). The frequency of AC genotype in patients is more than the control group. However, there was no statistically significant difference genotype distribution between the type 2 diabetes patients and control group for IGF2BP2 rs4402960 (G/T) gene polymorphisms. There was no association between the patients and the control group for TT and GG+GT genotype distribution (p=0.8847).
Conclusions: The results showed that the IGF2BP2 gene rs1470579 and rs4402960 polymorphisms were associated with T2D in a Turkish population (OR = 2.002, 95% CI 1.170–3.426, p < 0.05; OR = 1.879, 95% CI 1.110–3.182, p< 0.05). This is the first study between IGF2BP2 gene polymorphisms and type II diabetes in Turkish population.
Keywords: IGF2BP2, T2D, Polymorphism
Anahtar Kelimeler
Destekleyen Kurum
This study was supported by Mersin University Rectorate Scientific Research Projects Unit as a project coded BAP-SBE TTB (DY) 2013-3 YL.
Proje Numarası
BAP-SBE TTB (DY) 2013-3 YL
Etik Beyan
This study was approved by Mersin University Rectorate Clinical Research Ethics Committee with decision number 2012/370 dated 22.11.2012.
Kaynakça
- Uma Jyothi K, Mohan Reddy B. Gene–gene and gene–environment interactions in the etiology of type 2 diabetes mellitus in the population of Hyderabad India. Meta Gene 2015;5: 9–20.
- International Diabetes Federation, IDF Diabetes Atlas. 7th ed. Belgium, Brussels. 2015.
- Desiderio A, Spinelli R, Ciccarelli M, Nigro C, Miele C, Beguinot F, et al. Epigenetics: spotlight on type 2 diabetes and obesity. Journal of Endocrinological Investigation 2016; 39: 1095-1103.
- Uma Jyothi K, Mohan Reddy B. Genetic etiology of type 2 diabetes mellitus: a review. International Journal of Diabetes in Developing Countries 2011; 31: 51-64.
- The Diabetes Genetics Replication and Meta-analysis (DIAGRAM) Consortium. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nature genetics 2012; 44: 981-990.
- MacArthur J, Bowler E, Cerezo M, Gil L, Hall P, Hastings E, et al. The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog). Nücleic acids research 2017; 45: 896-901.
- Groenewoud MJ, Dekker JM, Fritsche A, Nijpels G, Heine RJ, Maassen JA, et al. Variants of CDKAL1 and IGF2BP2 affect firstphase insulin secretion during hyperglycaemic clamps. Diabetologia 2008; 51:1659–1663.
- Koster JC, Marshall BA, Ensor N, Corbett JA, Nichols CG. Targeted overactivity of β cell K ATP channels induces profound neonatal diabetes. Cell 2000; 100: 645–654.
- Takeuchi F, Serizawa M, Yamamoto K, Fujisawa T, Nakashima E, Ohnaka K, et al. Confirmation of multiple risk loci and genetic impacts by a genome-wide association study of type 2 diabetes in the Japanese population. Diabetes 2009; 58: 1690–1699.
- Huang Q, Yin JY, Dai XP, Pei Q, Dong M, Zhou ZG, et al. IGF2BP2 variations influence repaglinide response and risk of type 2 diabetes in Chinese population. Acta Pharmacol Sin 2010; 31: 709–717.